Form D · Other Health Care

XENGEN, INC.

Las Vegas, NV · CIK 0001613124

Offering snapshot reported Jul 10, 2014 · SEC filing

Reported sold
$12.5K
Offering amount: $500K
Investors reported
1
Form D · investor count
Minimum accepted
$12.5K
Reported outside-investor minimum
First sale
Jun 24, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 10, 2014Initial$12,500No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b, 4a5
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-220668
None have been paid or earned to date, although we have a potential for up to 10% in our offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Fernando LagudaNone
Bill RossNone
Rene CouchNone
David FlynnNone
Johnny ReadNone

Source: Form D, filed Jul 10, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rene Leon Couch Executive
David Michael Flynn Executive
Johnny Read Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
7455 Arroyo Crossing Suite 220
Las Vegas, NV, 89113